AGXT and metabolic dysfunction-associated steatotic liver disease: Notably, a significant inverse correlation was found between AGXT protein abundance and liver oxalate levels (Extended Data Fig. 1d) as well as MASH severity as determined by blinded histopathological analysis of the NAFLD activity score (NAS; Extended Data Fig. 1e).